BRIEF published on 01/12/2026 at 22:05, 6 months 29 days ago DBV Technologies met à jour ses droits de vote et ses actions au 31 décembre 2025 Droit De Vote NYSE Euronext Paris Mise À Jour Des Actions Décembre 2025 Technologies DBV
BRIEF published on 01/12/2026 at 22:05, 6 months 29 days ago DBV Technologies: Status of voting rights and shares as of December 31, 2025 Share Capital Voting Rights Actions NYSE Euronext DBV Technologies
BRIEF published on 01/12/2026 at 22:05, 6 months 29 days ago DBV Technologies Updates Voting Rights and Shares as of December 31, 2025 Voting Rights DBV Technologies NYSE Euronext Paris Shares Update December 2025
BRIEF published on 01/12/2026 at 22:05, 6 months 29 days ago DBV Technologies : État des droits de vote et actions au 31 décembre 2025 Droits De Vote Capital Social Actions NYSE Euronext DBV Technologies
PRESS RELEASE published on 01/12/2026 at 22:00, 6 months 29 days ago Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 Press release on total number of voting rights and shares of the Company as of December 31, 2025, in compliance with Article 223-16 of AMF General Regulations Voting Rights Shares AMF Regulations NYSE Euronext Paris December 31 2025
PRESS RELEASE published on 01/12/2026 at 22:00, 6 months 29 days ago Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025 Rapport sur les droits de vote et actions au 31 décembre 2025, incluant des informations sur le capital social et les opérations financières de la Société Droits De Vote Capital Social Actions AMF NYSE Euronext Paris
BRIEF published on 12/16/2025 at 22:10, 7 months 25 days ago DBV Technologies Reports Positive Phase 3 Results for VIASKIN Peanut Patch Phase 3 Trial Child Health Viaskin Peanut Peanut Allergy BLA Submission
BRIEF published on 12/16/2025 at 22:10, 7 months 25 days ago DBV Technologies : Résultats Encourageants de l'étude VITESSE sur le Patch Anti-Allergie à l'Arachide DBV Technologies Résultats Cliniques Viaskin Peanut Allergie Arachide Étude VITESSE
BRIEF published on 12/16/2025 at 22:10, 7 months 25 days ago DBV Technologies annonce des résultats positifs de phase 3 pour le patch VIASKIN Peanut. Essai De Phase 3 Allergie Aux Arachides VIASKIN Cacahuète Soumission De BLA Santé Infantile
BRIEF published on 12/16/2025 at 22:10, 7 months 25 days ago DBV Technologies: Encouraging Results from the VITESSE Study on the Peanut Allergy Patch DBV Technologies Clinical Results Viaskin Peanut Peanut Allergy SPEED Study
Published on 08/11/2026 at 14:30, 2 hours 16 minutes ago ACCESS Newswire Reports Second Quarter 2026 Results
Published on 08/11/2026 at 14:30, 2 hours 16 minutes ago AIAI Holdings' Constellation Network Launches Dôr Retail Intelligence: Transformational AI-Powered Retail Intelligence
Published on 08/11/2026 at 14:00, 2 hours 46 minutes ago First Canadian Graphite Signs Agreement with Groupe Nipi, in Collaboration with BBA, for its Preliminary Environmental Study at Lac Guéret Sud
Published on 08/11/2026 at 14:00, 2 hours 46 minutes ago First Canadian Graphite conclut une entente avec le Groupe Nipi en collaboration avec la firme BBA pour une étude environnementale préliminaire au Lac Guéret Sud
Published on 08/11/2026 at 13:30, 3 hours 16 minutes ago Nextech3D.ai CEO Evan Gappelberg Purchases 250,000 Shares in Open Market
Published on 08/11/2026 at 15:57, 49 minutes ago Medios Acquires a 74% Majority Stake in Caelo and Strengthens Its German and European Business in Active Pharmaceutical Ingredients and Excipients
Published on 08/10/2026 at 18:00, 22 hours 46 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 22 hours 46 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 11:53, 1 day 4 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
